Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies have found associations between the use of central nervous system medication and the risk of cognitive decline in the aged. Our aim was to assess whether the use of a single central nervous system (CNS) medication and, on the other hand, the combined use of multiple CNS medications over time are related to the risk of cognitive decline in an older (≥ 65 yrs) population that is cognitively intact at baseline. METHODS: We conducted a longitudinal population-based study of cognitively intact older adults. The participants were 65 years old or older and had Mini-Mental State Examination (MMSE) sum scores of 24 points or higher. The study included a 7.6-year follow-up. The use of benzodiazepines and related drugs (BZDs), antipsychotics (APs), antidepressants (ADs), opioids (Ops), anticholinergics (AChs) and antiepileptics (AEs) was determined at baseline and after a 7.6-years of the follow-up period. Cognitive functioning was used as an outcome variable measured with MMSE at baseline and at the mean follow-up of 7.6 years. Control variables were adjusted with analyses of covariance. RESULTS: After adjusting for control variables, the use of Ops and the concomitant use of Ops and BZDs as well as the use of Ops and any CNS medication were associated with cognitive decline. The use of AChs was associated with decline in cognitive functioning only in men. CONCLUSIONS: Of all the CNS medications analyzed in this study, the use of Ops may have the greatest effect on cognitive functioning in the ageing population. Due to small sample sizes these findings cannot be generalized to the unselected ageing population. More studies are needed concerning the long-term use of CNS medications, especially their concomitant use, and their potential cognitive effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cognitive deficits can lead to diminished physical capabilities, impaired balance, and an increased risk of falls, potentially deterring patients from participating in progressive balance exercises [[581], [582], [583], [584]].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [583]
In the citing paper
“Many medications, such as benzodiazepines, opioids, and anticholinergics, can cause side effects at the central nervous system, including sedation and cognitive impairment, which may exacerbate sarcopenia and compromise coordination and dual-task performance.”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [583]
In the citing paper
“Many medications, such as benzodiazepines, opioids, and anticholinergics, can cause side effects at the central nervous system, including sedation and cognitive impairment, which may exacerbate sarcopenia and compromise coordination and dual-task performance. These cognitive deficits can lead to diminished physical capabilities, impaired balance, and an increased risk of falls, potentially deter”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [583]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 11×
“The significances of changes in MMSE sum scores during the follow-up in the total population and in all subgroups were tested using the Wilcoxon signed rank test.”
BackgroundMethodInfluentialFick, D. M., Cooper, J. W., Wade, W. E., Waller, J. L., Maclean, J. R., & Beers, M. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2716 · Cited by 2,389 · cited 2×
“The groups of medications defined as those with an effect on the central nervous system (CNS) and used in the analyses of this study were as follows: benzodiazepines and related drugs (BZDs) (ATC codes N05BA, N05CD, N03AE01, N05CF, A03CA, C01DA70, M05AA51, N06CA01, N02BA71), antipsychotics (APs) (ATC codes N05A, N06CA…”
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A.-M., Touchon, J., & Ritchie, K. (2006) · BMJ · doi:10.1136/bmj.38740.439664.de · Cited by 589
Use of medications and polypharmacy are increasing among the elderly
Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivelä, S.-L., & Isoaho, R. (2002) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00411-0 · Cited by 509 · cited 4×
“Of these, 1,196 (93%, 488 men and 708 women) participated [12-15].”
BackgroundMethodResultInfluentialSelf-citationStarr, J. M. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.1.70 · Cited by 434 · cited 1×
“The blood-brain barrier permeability of different anticholinergic medications may differ depending on molecules [28], age [29] or disease states [30], which might explain why the risk of cognitive deterioration was detected only among men.”
BackgroundThe epidemiology of the dementias: an update
Qiu, C., De Ronchi, D., & Fratiglioni, L. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32816ebc7b · Cited by 418 · cited 1×
“Previously known risk factors of cognitive decline [20] such as age, sex, basic education, hypertension, atrial fibrillation or flutter, diabetes mellitus, congestive heart disease and smoking at the baseline were used as control factors.”
MethodCarrière, I., Fourrier-Reglat, A., Dartigues, J.-F., Rouaud, O., Pasquier, F., Ritchie, K., & Ancelin, M.-L. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.229 · Cited by 374
Paterniti, S., Dufouil, C., & Alpérovitch, A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200206000-00009 · Cited by 313 · cited 2×
“These relationships are previously studied mainly for the use of BZDs, and the results are controversial [3-6,24,25].”
BackgroundResultEffects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System
Todorova, A., Vonderheid‐Guth, B., & Dimpfel, W. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010528 · Cited by 271 · cited 2×
“The blood-brain barrier permeability of different anticholinergic medications may differ depending on molecules [28], age [29] or disease states [30], which might explain why the risk of cognitive deterioration was detected only among men.”
BackgroundThe Mini-Mental State Examination in General Medical Practice: Clinical Utility and Acceptance
Tangalos, E. G., Smith, G. E., Ivnik, R. J., Petersen, R. C., Kokmen, E., Kurland, L. T., Offord, K. P., & Parisi, J. E. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.9.829 · Cited by 260 · cited 1×
“The MMSE cut off point 24/23 provides a sensitivity of 69% and a specificity of 99% for dementia [21].”
Background
Research works printed but not linked: 2
- National Agency of Medicines: Classification of Medicines (ATC) and Defined Daily Doses (DDD). 1996, Helsinki
- Socialstyrelsen: Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi [Indicators for evaluating the quality of medication therapy in the aged]. 2003, Stockholm, Report No.: 2003-110-20: 74
Cited by
Grace, P. M., Strand, K. A., Galer, E. L., Urban, D. J., Wang, X., Baratta, M. V., Fabisiak, T. J., Anderson, N. D., Cheng, K., Greene, L. I., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602070113 · Cited by 367
“For example, opioids may also serve as a second hit for glia primed by aging or inflammation/trauma and may lead to cognitive decline in the elderly (63), postoperative cognitive decline (64), and impaired recovery of motor function after spinal cord injury (65, 66).”
BackgroundIzquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
The Role of Opioid Analgesics in Geriatric Pain Management
Naples, J. G., Gellad, W. F., & Hanlon, J. T. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.06.006 · Cited by 121
Pask, S., Dell’Olio, M., Murtagh, F. E., & Boland, J. W. (2019) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2019.10.022 · Cited by 74
Cognitive Effects and Sedation
Dhingra, L. K., Ahmed, E., Shin, J. G., Scharaga, E. A., & Magun, M. (2015) · Pain Medicine · doi:10.1111/pme.12912 · Cited by 67
Metadata
- Authors
- Puustinen, J., Nurminen, J., Löppönen, M., Vahlberg, T., Isoaho, R., Räihä, I., & Kivelä, S.-L.
- Affiliations
- University of Turku (FI)
- Corresponding author
- Puustinen, Juha
- Venue
- BMC Geriatrics
- Published
- 2011-11-01
- Volume
- 11
- Issue
- 1
- Pages
- 70-70
- ISSN
- 1471-2318 (ISSN-L)
- PMC
- PMC3226547
- OpenAlex
- W1993777947
- Cited by
- 51
- References
- 29
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 1 · 2022: 7 · 2021: 3 · 2020: 4 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 1 · 2013: 4 · 2012: 4
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Geriatrics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- central nervous system drugs, cognitive decline, older adults, opioids, benzodiazepines, antipsychotic drugs, antidepressants, anticholinergic agents, antiepileptic drugs, polypharmacy, drug-drug interactions, sex differences, cognitive aging
- MeSH terms
- Aged, Aged, 80 and over, Analgesics, Opioid, Benzodiazepines, Central Nervous System Agents, Cognition Disorders, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Longitudinal Studies, Male, Brief Psychiatric Rating Scale, Population Surveillance, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. https://app.cochat.ai/papers/10.1186/1471-2318-11-70
- The paper
- Puustinen, J., Nurminen, J., Löppönen, M., Vahlberg, T., Isoaho, R., Räihä, I., & Kivelä, S.-L. (2011). Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. BMC Geriatrics. https://doi.org/10.1186/1471-2318-11-70
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.